Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 17 February 2009
Vol. 2, Issue 58, p. ec66
[DOI: 10.1126/scisignal.258ec66]

EDITORS' CHOICE

Neuroscience GPR3 and Alzheimer’s Disease

Stella Hurtley

Science, AAAS, Cambridge CB2 1LQ, UK

Accumulation of the amyloid-β peptide (Aβ) is thought to represent a central problem in the pathogenesis of Alzheimer’s disease. Aside from the two proteases responsible for the generation of this peptide, few additional potential drug targets for the treatment of Alzheimer’s disease have emerged. Thathiah et al. describe an extensive high-throughput screen that sought to identify modulators of Aβ production. This functional genomics effort identified the G protein–coupled receptor GPR3 as a modulator of Aβ production. GPR3 has been mapped to a chromosomal locus associated with increased risk for Alzheimer’s disease; is highly expressed in hippocampus and cortex, regions of the brain that strongly correlate with Alzheimer's disease progression; and thus represents an attractive drug target.

A. Thathiah, K. Spittaels, M. Hoffmann, M. Staes, A. Cohen, K. Horré, M. Vanbrabant, F. Coun, V. Baekelandt, A. Delacourte, D. F. Fischer, D. Pollet, B. De Strooper, P. Merchiers, The orphan G protein–coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science 323, 946–951 (2009). [Abstract] [Full Text]

Citation: S. Hurtley, GPR3 and Alzheimer’s Disease. Sci. Signal. 2, ec66 (2009).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882